Preferred Label : recombinant proteins;

MeSH definition : Proteins prepared by recombinant DNA technology.;

MeSH synonym : proteins, recombinant; proteins, biosynthetic; biosynthetic proteins; Recombinant Protein; Protein, Recombinant; Biosynthetic Protein; Protein, Biosynthetic;

MeSH hyponym : proteins, recombinant DNA; DNA Proteins, Recombinant; Recombinant DNA Proteins; DNA Recombinant Proteins; Proteins, DNA Recombinant; Recombinant Proteins, DNA;

MeSH annotation : IM general only; coordinate NIM with specific protein;

Is substance : O;

Details


Main resources

You can consult :

Proteins prepared by recombinant DNA technology.

https://ansm.sante.fr/informations-de-securite/veyvondiv-vonicog-alfa-facteur-von-willebrand-humain-recombinant-poudre-et-solvant-pour-solution-injectable-mises-en-garde-sur-la-lecture-du-dosage-du-produit-et-sur-le-calcul-du-nombre-de-flacons-necessaires-vmedicament-sous-surveillance-ren
2023
false
false
false
France
French
product surveillance, postmarketing
drug information
Vonicog Alfa
recombinant proteins
von willebrand factor
injections, intravenous
hemorrhage
hemorrhage
adult
von willebrand diseases
blood loss, surgical
blood loss, surgical

---
https://www.cochrane.org/fr/CD001127/CF_la-dornase-alfa-un-medicament-inhale-dans-le-traitement-des-maladies-pulmonaires-chez-les-personnes
2021
false
true
false
France
United Kingdom
lung diseases
recombinant proteins
deoxyribonuclease i
treatment outcome
review of literature
french abstract
dornase alfa
cystic fibrosis

---
https://www.cochrane.org/fr/CD007923/CF_determination-du-moment-de-linhalation-de-la-dornase-alfa-chez-les-personnes-atteintes-de
2021
false
true
false
France
United Kingdom
dornase alfa
deoxyribonuclease i
treatment outcome
review of literature
french abstract
cystic fibrosis
administration, inhalation
deoxyribonuclease i
recombinant proteins

---
https://www.has-sante.fr/jcms/p_3258709/fr/ruconest
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
conestat alfa
child
adolescent
adult
angioedemas, hereditary
Hereditary angioedema attack
complement inactivating agents
evaluation of the transparency committee
conestat alfa
complement C1 inhibitor protein
recombinant proteins

---
https://www.has-sante.fr/jcms/p_3225401/fr/besremi
2020
false
false
false
France
treatment outcome
insurance, health, reimbursement
Ropeginterferon Alfa-2B
Ropeginterferon Alfa-2B
ropeginterferon alfa-2b
peginterferon alfa-2b
injections, subcutaneous
adult
polycythemia vera
evaluation of the transparency committee
interferon-alpha
recombinant proteins
Interferon alpha-2
polyethylene glycols

---
https://www.has-sante.fr/jcms/p_3221966/fr/palynziq
2020
false
false
false
France
treatment outcome
insurance, health, reimbursement
pegvaliase
pegvaliase
pegvaliase
injections, subcutaneous
phenylketonurias
guidelines for drug use
orphan drug production
enzyme replacement therapy
adult
young adult
drug hypersensitivity
continuity of patient care
evaluation of the transparency committee
phenylalanine ammonia-lyase
recombinant proteins
phenylalanine ammonia-lyase
recombinant proteins

---
https://www.ema.europa.eu/en/medicines/human/EPAR/nyvepria
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
pegfilgrastim
pegfilgrastim
pegfilgrastim
biosimilar pharmaceuticals
Chemotherapy-Induced febrile neutropenia
Chemotherapy induced neutropenia
injections, subcutaneous
product surveillance, postmarketing
adult
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols

---
https://www.has-sante.fr/jcms/p_3193753/fr/increlex
2020
false
false
false
France
mecasermin
insurance, health, reimbursement
child
adolescent
failure to thrive
insulin-like growth factor i
Growth delay due to insulin-like growth factor type 1 deficiency (disorder)
evaluation of the transparency committee
mecasermin
insulin-like growth factor i
recombinant proteins
insulin-like growth factor i
recombinant proteins

---
https://www.has-sante.fr/jcms/p_3191905/fr/grasustek
2020
false
false
false
France
biosimilar pharmaceuticals
pegfilgrastim
pegfilgrastim
insurance, health, reimbursement
treatment outcome
injections, subcutaneous
adult
Chemotherapy-Induced febrile neutropenia
Chemotherapy-Induced febrile neutropenia
evaluation of the transparency committee
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols

---
https://www.has-sante.fr/jcms/p_3181643/fr/cegfila
2020
false
false
false
France
biosimilar pharmaceuticals
pegfilgrastim
adult
treatment outcome
insurance, health, reimbursement
Chemotherapy-Induced febrile neutropenia
Chemotherapy-Induced febrile neutropenia
pegfilgrastim
evaluation of the transparency committee
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols

---
https://www.ansm.sante.fr/actualites/mecasermine-increlex-et-risque-de-tumeur-benigne-ou-maligne-extension-de-la-contre-indication
2020
false
false
false
France
French
neoplasms
mecasermin
mecasermin
mecasermin
child
adolescent
failure to thrive
pharmacovigilance note
insulin-like growth factor i
guidelines for drug use
insulin-like growth factor i
recombinant proteins
insulin-like growth factor i
recombinant proteins

---
https://ansm.sante.fr/uploads/2020/03/05/85b70141e0ccefd2207b2892e56bb885.pdf
2020
false
false
false
France
French
neoplasms
risk
mecasermin
pharmacovigilance note
child
adolescent
mecasermin
insulin-like growth factor i
failure to thrive
mecasermin
mecasermin
insulin-like growth factor i
recombinant proteins
insulin-like growth factor i
recombinant proteins
insulin-like growth factor i
recombinant proteins

---
https://www.ema.europa.eu/en/medicines/human/EPAR/udenyca
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
pegfilgrastim
pegfilgrastim
biosimilar pharmaceuticals
neutropenia
Chemotherapy-Induced febrile neutropenia
Chemotherapy induced neutropenia
neutropenia
antineoplastic agents
injections, subcutaneous
pegfilgrastim
product surveillance, postmarketing
adult
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols

---
https://www.ema.europa.eu/en/medicines/human/EPAR/palynziq
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
pegvaliase
pegvaliase
orphan drug production
adult
adolescent
phenylketonurias
continuity of patient care
injections, subcutaneous
phenylalanine
product surveillance, postmarketing
pregnancy
breast feeding
drug evaluation, preclinical
pegvaliase
enzyme replacement therapy
phenylalanine ammonia-lyase
recombinant proteins
phenylalanine ammonia-lyase
recombinant proteins

---
https://www.has-sante.fr/jcms/p_3106643/fr/fulphila
2019
false
false
false
France
pegfilgrastim
treatment outcome
pegfilgrastim
adult
Chemotherapy-Induced febrile neutropenia
biosimilar pharmaceuticals
evaluation of the transparency committee
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00430
2019
false
false
false
Canada
French
drug information
drug approval
canada
treatment outcome
cerliponase alfa
cerliponase alfa
cerliponase alfa
enzyme replacement therapy
ceroid lipofuscinosis, neuronal, 2
child
adult
infusions, intraventricular
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
recombinant proteins
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
recombinant proteins
neuronal ceroid-lipofuscinoses

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00432
2019
false
false
false
Canada
French
drug information
drug approval
canada
treatment outcome
injections, subcutaneous
pegfilgrastim
pegfilgrastim
pegfilgrastim
Chemotherapy-Induced febrile neutropenia
adult
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols

---
https://www.ema.europa.eu/en/medicines/human/EPAR/ondexxya
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
andexanet alfa
andexanet alfa
hemorrhage
hemorrhage
apixaban
Rivaroxaban
antidotes
antidotes
adult
infusions, intravenous
Factor Xa Inhibitors
andexanet alfa
product surveillance, postmarketing
pregnancy
breast feeding
Anticoagulant reversal therapy
PRT064445
PRT064445
recombinant proteins
factor xa
recombinant proteins
factor xa
pyrazoles
pyridones

---
https://www.ema.europa.eu/en/medicines/human/EPAR/grasustek
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
pegfilgrastim
pegfilgrastim
pegfilgrastim
Chemotherapy-Induced febrile neutropenia
leukemia, myelogenous, chronic, bcr-abl positive
myelodysplastic syndromes
Chemotherapy induced neutropenia
neutropenia
neutropenia
antineoplastic agents
injections, subcutaneous
product surveillance, postmarketing
adult
drug interactions
pregnancy
breast feeding
biosimilar pharmaceuticals
drug evaluation, preclinical
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols

---
https://www.ema.europa.eu/en/medicines/human/EPAR/pegfilgrastim-mundipharma
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
pegfilgrastim
pegfilgrastim
Chemotherapy-Induced febrile neutropenia
Chemotherapy induced neutropenia
neutropenia
neutropenia
antineoplastic agents
biosimilar pharmaceuticals
injections, subcutaneous
pegfilgrastim
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols

---
https://www.has-sante.fr/jcms/p_3108945/fr/lonquex
2019
false
false
false
France
insurance, health, reimbursement
treatment outcome
lipegfilgrastim
injections, subcutaneous
lipegfilgrastim
adult
Chemotherapy-Induced febrile neutropenia
neutropenia
evaluation of the transparency committee
pegfilgrastim
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols

---
https://www.ema.europa.eu/en/medicines/human/EPAR/besremi
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Ropeginterferon Alfa-2B
Ropeginterferon Alfa-2B
peginterferon alfa-2b
drug approval
europe
polycythemia vera
adult
ropeginterferon alfa-2b
orphan drug production
injections, subcutaneous
receptor, interferon alpha-beta
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
interferon-alpha
recombinant proteins
Interferon alpha-2
polyethylene glycols

---
https://www.has-sante.fr/portail/jcms/c_2966040/fr/inductos
https://www.has-sante.fr/jcms/c_2966040/fr/inductos-dibotermine-alpha-proteine-osteo-inductrice
2019
false
false
false
false
France
dibotermin alfa
lumbar spinal fusion
transforming growth factor beta
bone morphogenetic protein 2
recombinant proteins
intervertebral disc degeneration
guidelines for drug use
evaluation of the transparency committee
recombinant human bone morphogenetic protein-2
recombinant proteins
transforming growth factor beta
bone morphogenetic protein 2

---
https://www.has-sante.fr/portail/jcms/c_2965047/fr/adynovi
https://www.has-sante.fr/portail/jcms/c_2965047/fr/adynovi-rurioctocog-alfa-pegol-facteur-anti-hemophilique-facteur-viii
2019
false
false
false
France
French
treatment outcome
hemophilia A
hemorrhage
hemorrhage
adult
adolescent
aged
injections, intravenous
factor VIII
recombinant proteins
coagulation factor VIII
evaluation of the transparency committee
guidelines for drug use

---
https://www.has-sante.fr/portail/jcms/c_2905739/fr/ruconest
2019
false
false
false
France
conestat alfa
conestat alfa
evaluation of the transparency committee
complement C1 inhibitor protein
recombinant proteins

---
https://www.has-sante.fr/jcms/p_3135363/fr/pelgraz
2019
false
false
false
France
French
pegfilgrastim
evaluation of the transparency committee
Injection moulding
Solutions
devices
injections
solutions
Set, Psychology
solution, nos
injection, nos
device, nos
Intraspinal abscess
equipment and supplies
solutions
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols

---
https://www.has-sante.fr/portail/jcms/c_2900187/fr/pelmeg
2019
false
false
false
France
French
treatment outcome
Chemotherapy-Induced febrile neutropenia
biosimilar pharmaceuticals
pegfilgrastim
injections, subcutaneous
evaluation of the transparency committee
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols

---
https://www.ema.europa.eu/en/medicines/human/EPAR/ziextenzo
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
biosimilar pharmaceuticals
pegfilgrastim
pegfilgrastim
pegfilgrastim
neutropenia
neutropenia
antineoplastic agents
Chemotherapy-Induced febrile neutropenia
injections, subcutaneous
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols

---
https://www.has-sante.fr/portail/jcms/c_2892924/fr/ziextenzo
2019
false
false
false
France
French
pegfilgrastim
treatment outcome
biosimilar pharmaceuticals
evaluation of the transparency committee
pegfilgrastim
Chemotherapy-Induced febrile neutropenia
Chemotherapy induced neutropenia
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols

---
https://www.inesss.qc.ca/index.php?id=72&DemandePluginController%5Buid%5D=4526&DemandePluginController%5Bonglet%5D=2&DemandePluginController%5BbackUrl%5D=%252Findex.php%253Fid%253D72%2526no_cache%253D1%2526DemandePluginController%25255Buid%25255D%253D4469%2526DemandePluginController%25255Bonglet%25255D%253D2%2526DemandePluginController%25255BbackUrl%25255D%253D%2525252Findex.php%2525253Fid%2525253D72%25252526no_cache%2525253D1%25252526DemandePluginController%252525255Buid%252525255D%2525253D4496%25252526DemandePluginController%252525255Bonglet%252525255D%2525253D2&cHash=5e70eb8df42c4346c411ee357a44aff6
2018
false
false
false
Canada
French
drug evaluation
pegfilgrastim
pegfilgrastim
granulocyte colony-stimulating factor
recombinant proteins

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00396
2018
false
true
false
Canada
French
English
drug information
pegfilgrastim
pegfilgrastim
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols

---
https://www.has-sante.fr/portail/jcms/c_2825852/fr/refixia
2018
false
false
false
false
France
French
evaluation of the transparency committee
nonacog beta pegol
coagulation factor IX
hemorrhage
hemorrhage
treatment outcome
hemophilia B
injections, intravenous
factor IX
polyethylene glycols
recombinant proteins

---
https://www.ema.europa.eu/medicines/human/EPAR/Adynovi
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treatment outcome
hemophilia A
hemorrhage
hemorrhage
adult
adolescent
aged
injections, intravenous
factor VIII
recombinant proteins
recombinant proteins
coagulation factor VIII
product surveillance, postmarketing
continuity of patient care
drug evaluation, preclinical

---
https://www.has-sante.fr/portail/jcms/c_2820103/fr/oxervate-cenegermine-forme-recombinante-du-facteur-de-croissance-des-cellules-nerveuses-humain
https://www.has-sante.fr/portail/jcms/c_2820103/fr/oxervate
2018
false
false
false
France
French
treatment outcome
nerve growth factor
Neurotrophic keratopathy
keratitis
adult
ophthalmic solutions
administration, ophthalmic
recombinant proteins
recombinant proteins
cenegermin
evaluation of the transparency committee
guidelines for drug use
cenegermin

---
https://www.ema.europa.eu/medicines/human/EPAR/Veyvondi
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treatment outcome
von Willebrand factor
product surveillance, postmarketing
hemorrhage
blood loss, surgical
blood loss, surgical
von willebrand diseases
von willebrand factor
injections, intravenous
adult
pregnancy
breast feeding
recombinant proteins
drug evaluation, preclinical

---
https://www.has-sante.fr/portail/jcms/c_2873722/fr/ruconest
https://www.has-sante.fr/portail/jcms/c_2873722/fr/ruconest-conestat-alpha-medicaments-de-l-angioedeme-hereditaire
2018
false
false
false
France
conestat alfa
treatment outcome
conestat alfa
guidelines for drug use
angioedemas, hereditary
injections, intravenous
adult
evaluation of the transparency committee
complement C1 inhibitor protein
recombinant proteins

---
https://www.ema.europa.eu/en/medicines/human/EPAR/pelgraz
2018
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
pegfilgrastim
pegfilgrastim
biosimilar pharmaceuticals
pegfilgrastim
neutropenia
Chemotherapy-Induced febrile neutropenia
neutropenia
antineoplastic agents
injections, subcutaneous
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols

---
https://www.ema.europa.eu/en/medicines/human/EPAR/fulphila-0
2018
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
pegfilgrastim
pegfilgrastim
pegfilgrastim
biosimilar pharmaceuticals
antineoplastic agents
neutropenia
neutropenia
injections, subcutaneous
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Chemotherapy-Induced febrile neutropenia
Chemotherapy induced neutropenia
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols

---
https://www.ema.europa.eu/en/medicines/human/EPAR/pelmeg
2018
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Chemotherapy-Induced febrile neutropenia
drug approval
europe
biosimilar pharmaceuticals
pegfilgrastim
pegfilgrastim
injections, subcutaneous
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Chemotherapy induced neutropenia
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols

---
https://www.has-sante.fr/portail/jcms/c_2888499/fr/pelgraz
2018
false
false
false
France
treatment outcome
pegfilgrastim
pegfilgrastim
biosimilar pharmaceuticals
Chemotherapy-Induced febrile neutropenia
injections, subcutaneous
pegfilgrastim
adult
insurance, health, reimbursement
evaluation of the transparency committee
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols
granulocyte colony-stimulating factor
recombinant proteins
Filgrastim
polyethylene glycols

---
https://www.has-sante.fr/portail/jcms/c_2860526/fr/pegasys
2018
false
false
false
false
France
French
evaluation of the transparency committee
child
adolescent
peginterferon alfa-2a
peginterferon alfa-2a
hepatitis B, chronic
injections, subcutaneous
treatment outcome
antiviral agents
antiviral agents
insurance, health, reimbursement
peginterferon alfa-2a
polyethylene glycols
interferon-alpha
recombinant proteins
polyethylene glycols
interferon-alpha
recombinant proteins

---
https://www.has-sante.fr/portail/jcms/c_2860529/fr/bivalirudine-accord
2018
false
false
false
false
France
French
evaluation of the transparency committee
bivalirudin
bivalirudin
hirudins
peptide fragments
recombinant proteins

---
Refixia - nonacog beta pegol
https://www.ema.europa.eu/medicines/human/EPAR/Refixia
2017
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
nonacog beta pegol
nonacog beta pegol
coagulation factor IX
treatment outcome
product surveillance, postmarketing
hemorrhage
hemorrhage
hemophilia B
hemophilia B
adult
adolescent
aged
injections, intravenous
drug evaluation, preclinical
factor IX
polyethylene glycols
recombinant proteins
factor IX
polyethylene glycols
recombinant proteins

---
https://www.has-sante.fr/portail/jcms/c_2788650/fr/afstyla
2017
false
false
false
France
French
treatment outcome
factor VIII
factor VIII
hemophilia A
hemorrhage
hemorrhage
coagulation factor VIII
Product containing coagulation factor VIII (medicinal product)
injections, intravenous
adult
child
adolescent
aged
infant
recombinant proteins
recombinant proteins
evaluation of the transparency committee

---
Oxervate cenegermin
https://www.ema.europa.eu/medicines/human/EPAR/Oxervate
2017
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treatment outcome
nerve growth factor
orphan drug production
Neurotrophic keratopathy
keratitis
adult
ophthalmic solutions
administration, ophthalmic
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
recombinant proteins
recombinant proteins
cenegermin
cenegermin
cenegermin
nerve growth factor
nerve growth factor

---
http://www.has-sante.fr/portail/jcms/c_2733869/fr/roferon-a
2016
false
false
false
France
French
evaluation of the transparency committee
Roferon-A
due to
Anatomy Category
interferon-alpha
recombinant proteins
Interferon alpha-2

---
http://www.has-sante.fr/portail/jcms/c_2558862/fr/rixubis
2015
false
false
false
France
French
treatment outcome
coagulation factor IX
factor IX
factor IX
recombinant proteins
hemorrhage
hemorrhage
hemophilia B
injections, intravenous
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2570608/fr/neulasta
http://www.has-sante.fr/portail/jcms/c_697297/neulasta
http://www.has-sante.fr/portail/jcms/c_399819/fr/neulasta-6-mg-solution-injectable-boite-de-1-seringue-de-verre-preremplie
2015
false
true
false
false
France
French
evaluation of the transparency committee
pegfilgrastim
pegfilgrastim
injections, subcutaneous
insurance, health, reimbursement
treatment outcome
Chemotherapy-Induced febrile neutropenia
granulocyte colony-stimulating factor
recombinant proteins

---
https://www.sfpediatrie.com/sites/www.sfpediatrie.com/files/medias/documents/recommandations_erythropoietine_sfp_2015.pdf
2015
false
false
true
France
French
practice guideline
journal article
epoetin beta
erythropoietin
recombinant proteins
infant, premature
infant, newborn
blood transfusion
drug administration schedule
epoetin beta
erythropoietin
recombinant proteins
recombinant proteins

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=62170657
2015
false
false
false
France
French
summary of product characteristics
follitropin alfa
package leaflet
evaluation of the transparency committee
follicle stimulating hormone, human
recombinant proteins

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=62854032
2015
false
false
false
France
French
summary of product characteristics
follitropin alfa
package leaflet
evaluation of the transparency committee
follicle stimulating hormone, human
recombinant proteins

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=68954979
2015
false
false
false
France
French
summary of product characteristics
follitropin alfa
package leaflet
evaluation of the transparency committee
follicle stimulating hormone, human
recombinant proteins

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=64424905
2015
false
false
false
France
French
summary of product characteristics
package leaflet
evaluation of the transparency committee
follitropin alfa
follicle stimulating hormone, human
recombinant proteins

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=67933658
2015
false
false
false
France
French
summary of product characteristics
follitropin alfa
package leaflet
evaluation of the transparency committee
follicle stimulating hormone, human
recombinant proteins

---
https://www.ema.europa.eu/medicines/human/EPAR/Rixubis
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
coagulation factor IX
factor IX
factor IX
recombinant proteins
drug approval
europe
hemorrhage
hemorrhage
hemophilia B
injections, intravenous
risk management
drug monitoring
product surveillance, postmarketing
drug evaluation, preclinical

---
https://www.ema.europa.eu/medicines/human/EPAR/Ristempa
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
pegfilgrastim
pegfilgrastim
pegfilgrastim
drug approval
europe
Chemotherapy-Induced febrile neutropenia
Chemotherapy-Induced febrile neutropenia
injections, subcutaneous
Injectable Solution Dosage Form
Prefilled Syringe Dosage Form
adult
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Chemotherapy induced neutropenia
recombinant proteins
granulocyte colony-stimulating factor
recombinant proteins
granulocyte colony-stimulating factor

---
http://www.has-sante.fr/portail/jcms/c_1777273/fr/proleukin
2014
false
false
false
France
French
evaluation of the transparency committee
aldesleukin
aldesleukin
treatment outcome
antineoplastic agents
neoplasm metastasis
kidney neoplasms
Renal Cell Carcinoma
Metastatic Adenocarcinoma
adenocarcinoma
karnofsky performance status
infusions, intravenous
injections, subcutaneous
Progression-Free survival
disease-free survival
Interleukin-2
Interleukin-2
recombinant proteins

---
http://www.has-sante.fr/portail/jcms/c_1745375/fr/lonquex-lipegfilgrastim-facteur-de-croissance-granulocytaire
2014
false
false
false
France
French
guidelines for drug use
evaluation of the transparency committee
lipegfilgrastim
lipegfilgrastim
lipegfilgrastim
injections, subcutaneous
neutropenia
Chemotherapy-Induced febrile neutropenia
adult
treatment outcome
insurance, health, reimbursement
pegfilgrastim
pegfilgrastim
recombinant proteins
granulocyte colony-stimulating factor
recombinant proteins
granulocyte colony-stimulating factor

---
http://www.has-sante.fr/portail/jcms/c_1735592/fr/pegasys
2014
false
France
French
child
adolescent
ribavirin
peginterferon alfa-2a
antiviral agents
insurance, health, reimbursement
hepatitis C, chronic
peginterferon alfa-2a
injections, subcutaneous
drug therapy, combination
treatment outcome
evaluation of the transparency committee
peginterferon alfa-2a
interferon-alpha
interferon-alpha
recombinant proteins
antiviral agents
recombinant proteins
polyethylene glycols
recombinant proteins
polyethylene glycols

---
http://www.has-sante.fr/portail/jcms/c_1735588/fr/pegasys
2014
false
France
English
peginterferon alfa-2a
antiviral agents
insurance, health, reimbursement
hepatitis C, chronic
peginterferon alfa-2a
injections, subcutaneous
drug therapy, combination
treatment outcome
evaluation of the transparency committee
hepatitis B, chronic
adult
peginterferon alfa-2a
interferon-alpha
interferon-alpha
recombinant proteins
antiviral agents
recombinant proteins
polyethylene glycols
recombinant proteins
polyethylene glycols

---
http://www.has-sante.fr/portail/jcms/c_2003871/fr/bemfola
http://www.has-sante.fr/portail/jcms/c_2003871/fr/bemfola-follitropine-alfa-recombinante-gonadotrophine
2014
false
false
false
France
French
evaluation of the transparency committee
follitropin alfa
follitropin alfa
treatment outcome
guidelines for drug use
superovulation
injections, subcutaneous
biosimilar pharmaceuticals
anovulation
spermatogenesis
hypogonadotropic hypogonadism
infertility, female
infertility, male
insurance, health, reimbursement
adult
Stimulation of spermatogenesis
Follicle stimulating hormone deficiency (disorder)
hypogonadism
follicle stimulating hormone, human
recombinant proteins
follicle stimulating hormone, human
recombinant proteins

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00231
2014
false
false
false
Canada
drug information
Galsulfase 1mg/mL injection solution 5mL vial (product)
galsulfase
galsulfase
N-Acetylgalactosamine-4-Sulfatase
recombinant proteins

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=69705653
2014
false
false
false
France
French
summary of product characteristics
package leaflet
solution, nos
injection, nos
powders
solutions
solvent, nos
activator appliances
injections
eptacog alfa
solutions
recombinant FVIIa
recombinant proteins
factor VIIa

---
http://www.cochrane.org/fr/CD005642/peg-interferon-alpha-2a-versus-peg-interferon-alpha-2b-pour-lhepatite-c-chronique
false
false
false
France
United Kingdom
meta-analysis
french abstract
peginterferon alfa-2a
peginterferon alfa-2b
interferon-alpha
interferon-beta
antiviral agents
hepatitis C, chronic
treatment outcome
peginterferon alfa-2a
peginterferon alfa-2b
interferon-alpha
interferon-beta
antiviral agents
hepatitis C, chronic
polyethylene glycols
recombinant proteins
polyethylene glycols
recombinant proteins

---
http://www.cochrane.org/fr/CD005385
2012
false
true
false
United Kingdom
France
drotrecogin alfa activated
protein C
treatment outcome
review of literature
french abstract
Neonatal Sepsis
infant, newborn
protein C
recombinant proteins

---
https://www.ema.europa.eu/medicines/human/EPAR/Rapilysin
2012
United Kingdom
French
English
syndication feed
tissue plasminogen activator
recombinant proteins
fibrinolytic agents
myocardial infarction
treatment outcome
drug evaluation
reteplase
reteplase
tissue plasminogen activator
recombinant proteins
drug evaluation
summary of product characteristics
package leaflet

---
https://www.ema.europa.eu/medicines/human/EPAR/Puregon
2012
United Kingdom
French
English
syndication feed
Contraindications, Procedure
infertility, female
follicle stimulating hormone, beta subunit
ovulation induction
follicle stimulating hormone, beta subunit
follicle stimulating hormone, beta subunit
follicle stimulating hormone, beta subunit
treatment outcome
drug evaluation
fertility agents
fertility agents
anovulation
fertility agents
fertility agents
hypogonadism
injections, intramuscular
injections, subcutaneous
recombinant proteins
recombinant proteins
recombinant proteins
recombinant proteins
follitropin beta
drug evaluation
summary of product characteristics
package leaflet
Contraindications, Drug

---
https://www.ema.europa.eu/medicines/human/EPAR/Angiox
2012
United Kingdom
French
English
syndication feed
angioplasty, balloon, coronary
hirudins
anticoagulants
hirudins
anticoagulants
peptide fragments
peptide fragments
recombinant proteins
recombinant proteins
acute coronary syndrome
bivalirudin
bivalirudin
bivalirudin
hirudins
peptide fragments
recombinant proteins
drug evaluation
package leaflet
summary of product characteristics

---
https://www.ema.europa.eu/medicines/human/EPAR/Aldurazyme
2012
United Kingdom
French
English
syndication feed
mucopolysaccharidosis I
iduronidase
iduronidase
infusions, intravenous
orphan drug production
recombinant proteins
drug evaluation
treatment outcome
drug approval
drug labeling
iduronidase
pregnancy
breast feeding
iduronidase
iduronidase
drug storage
drug compounding
laronidase
drug evaluation
summary of product characteristics
package leaflet

---
http://www.cochrane.org/fr/CD005011
2012
false
France
United Kingdom
French
french abstract
meta-analysis
recombinant FVIIa
factor VIIa
recombinant proteins
hemorrhage
hemorrhage
treatment outcome

---
http://www.prescrire.org/Fr/967211CF76811E81FB625FF51DFE054A/Download.aspx
http://formations.prescrire.org/fr/22/68/0/137/About.aspx
2010
false
true
false
false
France
anticoagulants
anticoagulants
bivalirudin
percutaneous coronary intervention
percutaneous coronary intervention
myocardial infarction
myocardial infarction
myocardial infarction
myocardial infarction
hirudins
integrins
cardiology
anticoagulotherapy
examination questions
critical appraisal or critical reading
hirudins
peptide fragments
recombinant proteins

---
https://www.cadth.ca/fr/facteur-vii-active-recombinant-dans-la-prevention-de-lhemorragie-non-liee-lhemophilie-etude
https://www.cadth.ca/sites/default/files/pdf/457B_Executive_Summary_f.pdf
2010
true
Canada
French
recombinant FVIIa
factor VIIa
recombinant proteins
hemorrhage
factor VIIa
recombinant proteins
health technology assessment
french abstract
economic evaluation
treatment outcome

---
http://francais.mcgill.ca/files/tau/Final_report_Drotrecogin_alfa.pdf
2007
Canada
French
English
protein C
recombinant proteins
sepsis
fibrinolytic agents
drotrecogin alfa activated
drotrecogin alfa (activated)
protein C
recombinant proteins
french abstract
drug evaluation

---
http://www.has-sante.fr/portail/display.jsp?id=c_245508
2004
France
French
factor VIIa
recombinant proteins
hemorrhage
hemorrhagic disorders
recombinant FVIIa
coagulation factor VIIa
factor VIIa
recombinant proteins
evaluation of the transparency committee

---
https://www.cadth.ca/sites/default/files/pdf/108_No38_bivalirudin_edrug_f.pdf
2003
Canada
French
anticoagulotherapy
angioplasty, balloon, coronary
angina, unstable
anticoagulants
aspirin
drug therapy, combination
peptide fragments
hirudins
recombinant proteins
fibrinolytic agents
clinical trials as topic
bivalirudin
drug evaluation

---
http://www.has-sante.fr/portail/display.jsp?id=c_244371
2002
France
French
protein C
recombinant proteins
anti-infective agents
adult
sepsis
drotrecogin alfa activated
drotrecogin alfa (activated)
protein C
recombinant proteins
guidelines for drug use

---
Nous contacter.
13/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.